Persistent asymptomatic isolated microscopic hematuria in Israeli adolescents and young adults and risk for end-stage renal disease - PubMed (original) (raw)
. 2011 Aug 17;306(7):729-36.
doi: 10.1001/jama.2011.1141.
Affiliations
- PMID: 21846854
- DOI: 10.1001/jama.2011.1141
Persistent asymptomatic isolated microscopic hematuria in Israeli adolescents and young adults and risk for end-stage renal disease
Asaf Vivante et al. JAMA. 2011.
Abstract
Context: Few data are available on long-term outcomes among adolescents and young adults with persistent asymptomatic isolated microscopic hematuria.
Objective: To evaluate the risk of end-stage renal disease (ESRD) in adolescents and young adults with persistent asymptomatic isolated microscopic hematuria.
Design, setting, and participants: Nationwide, population-based, retrospective cohort study using medical data from 1,203,626 persons aged 16 through 25 years (60% male) examined for fitness for military service between 1975 and 1997 were linked to the Israeli treated ESRD registry. Incident cases of treated ESRD from January 1, 1980, to May 31, 2010, were included. Cox proportional hazards models were used to estimate the hazard ratio (HR) of treated ESRD among those diagnosed as having persistent asymptomatic isolated microscopic hematuria.
Main outcome measures: Treated ESRD onset, defined as the date of initiation of dialysis treatment or the date of renal transplantation, whichever came first.
Results: Persistent asymptomatic isolated microscopic hematuria was diagnosed in 3690 of 1,203,626 eligible individuals (0.3%). During 21.88 (SD, 6.74) years of follow-up, treated ESRD developed in 26 individuals (0.70%) with and 539 (0.045%) without persistent asymptomatic isolated microscopic hematuria, yielding incidence rates of 34.0 and 2.05 per 100,000 person-years, respectively, and a crude HR of 19.5 (95% confidence interval [CI], 13.1-28.9). A multivariate model adjusted for age, sex, paternal country of origin, year of enrollment, body mass index, and blood pressure at baseline did not substantially alter the risk associated with persistent asymptomatic isolated microscopic hematuria (HR, 18.5 [95% CI, 12.4-27.6]). A substantially increased risk for treated ESRD attributed to primary glomerular disease was found for individuals with persistent asymptomatic isolated microscopic hematuria compared with those without the condition (incidence rates, 19.6 vs 0.55 per 100,000 person-years, respectively; HR, 32.4 [95% CI, 18.9-55.7]). The fraction of treated ESRD attributed to microscopic hematuria was 4.3% (95% CI, 2.9%-6.4%).
Conclusion: Presence of persistent asymptomatic isolated microscopic hematuria in persons aged 16 through 25 years was associated with significantly increased risk of treated ESRD for a period of 22 years, although the incidence and absolute risk remain quite low.
Comment in
- Has the time come to include urine dipstick testing in screening asymptomatic young adults?
Brown RS. Brown RS. JAMA. 2011 Aug 17;306(7):764-5. doi: 10.1001/jama.2011.1193. JAMA. 2011. PMID: 21846861 No abstract available. - Microscopic hematuria in adolescents and young adults and risk for end-stage renal disease.
Sarafidis PA. Sarafidis PA. JAMA. 2011 Nov 9;306(18):1980; author reply 1980-1. doi: 10.1001/jama.2011.1618. JAMA. 2011. PMID: 22068988 No abstract available. - ACP Journal Club. Young adults with persistent, asymptomatic, isolated microscopic hematuria were at increased risk for ESRD.
Molony DA. Molony DA. Ann Intern Med. 2011 Dec 20;155(12):JC6-12. doi: 10.7326/0003-4819-155-12-201112200-02012. Ann Intern Med. 2011. PMID: 22184713 No abstract available. - Evidence for asymptomatic microhematuria as a risk factor for the development of ESRD.
Iseki K. Iseki K. Am J Kidney Dis. 2012 Jul;60(1):12-4. doi: 10.1053/j.ajkd.2012.01.009. Epub 2012 Feb 18. Am J Kidney Dis. 2012. PMID: 22342318 No abstract available.
Similar articles
- Body mass index in 1.2 million adolescents and risk for end-stage renal disease.
Vivante A, Golan E, Tzur D, Leiba A, Tirosh A, Skorecki K, Calderon-Margalit R. Vivante A, et al. Arch Intern Med. 2012 Nov 26;172(21):1644-50. doi: 10.1001/2013.jamainternmed.85. Arch Intern Med. 2012. PMID: 23108588 Free PMC article. - Association of Adolescent Hypertension With Future End-stage Renal Disease.
Leiba A, Fishman B, Twig G, Gilad D, Derazne E, Shamiss A, Shohat T, Ron O, Grossman E. Leiba A, et al. JAMA Intern Med. 2019 Apr 1;179(4):517-523. doi: 10.1001/jamainternmed.2018.7632. JAMA Intern Med. 2019. PMID: 30801616 Free PMC article. - Prehypertension among 2.19 million adolescents and future risk for end-stage renal disease.
Leiba A, Twig G, Vivante A, Skorecki K, Golan E, Derazne E, Tzur D, Grossman E, Dichtiar R, Kark JD, Shohat T. Leiba A, et al. J Hypertens. 2017 Jun;35(6):1290-1296. doi: 10.1097/HJH.0000000000001295. J Hypertens. 2017. PMID: 28169886 - Hematuria in adolescents.
Gordon C, Stapleton FB. Gordon C, et al. Adolesc Med Clin. 2005 Feb;16(1):229-39. doi: 10.1016/j.admecli.2004.09.005. Adolesc Med Clin. 2005. PMID: 15844394 Review. - Evaluation of asymptomatic microscopic hematuria.
Grossfeld GD, Carroll PR. Grossfeld GD, et al. Urol Clin North Am. 1998 Nov;25(4):661-76. doi: 10.1016/s0094-0143(05)70055-0. Urol Clin North Am. 1998. PMID: 10026773 Review.
Cited by
- Noninvasive genetic testing for type IV collagen nephropathy using oral mucosa DNA sampling in children with haematuria.
Liu J, Zhou D, Wang X, Shen T, Wang C, Dai R, Han X, Huang L, Xu W, Chen J, Zhai Y, Rao J, Ma D, Shen Q, Xu H. Liu J, et al. Ren Fail. 2024 Dec;46(2):2423845. doi: 10.1080/0886022X.2024.2423845. Epub 2024 Nov 14. Ren Fail. 2024. PMID: 39540369 Free PMC article. - Detection of Alport gene variants in children and young people with persistent haematuria.
Ng NSL, Yamamura T, Shenoy M, Stuart HM, Lennon R. Ng NSL, et al. Pediatr Nephrol. 2024 Oct 1. doi: 10.1007/s00467-024-06538-8. Online ahead of print. Pediatr Nephrol. 2024. PMID: 39349776 - The impact of population ageing on the burden of chronic kidney disease.
Chesnaye NC, Ortiz A, Zoccali C, Stel VS, Jager KJ. Chesnaye NC, et al. Nat Rev Nephrol. 2024 Sep;20(9):569-585. doi: 10.1038/s41581-024-00863-9. Epub 2024 Jul 18. Nat Rev Nephrol. 2024. PMID: 39025992 Review. - Asymptomatic hematuria in children: Korean Society of Pediatric Nephrology recommendations for diagnosis and management.
Park E, Kim SW, Kim SJ, Baek M, Ahn YH, Yang EM, Cho MH, Lee HK, Han KH, Kim YL, Choi M, Kang HG, Suh JS. Park E, et al. Kidney Res Clin Pract. 2024 Sep;43(5):565-574. doi: 10.23876/j.krcp.23.231. Epub 2024 Mar 7. Kidney Res Clin Pract. 2024. PMID: 38738274 Free PMC article. - The efficacy and safety of hydroxychloroquine versus leflunomide in patients with IgA nephropathy: a single-center experience.
He WJ, Wang J, Liu N, Li GY, Zhu XW, Yao L, Liu LL. He WJ, et al. J Nephrol. 2024 May;37(4):933-940. doi: 10.1007/s40620-023-01839-x. Epub 2024 Jan 16. J Nephrol. 2024. PMID: 38225440 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical